Integrated Celltrion is launched with three CEOs: Ki Woo-sung, Kim Hyeong-ki, and Seo Jin-seok.

Reporter Kim Jisun / approved : 2023-12-29 00:18:05
  • -
  • +
  • 인쇄

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Celltrion has completed its merger with Celltrion Healthcare and is newly launched as an integrated Celltrion. In the future, integrated Celltrion will run its own three representative executive officers.

Vice Chairman Ki Woo-sung, who was formerly CEO of Celltrion, will oversee the manufacturing and development division, while Vice Chairman Kim Hyung-ki, who was CEO of Celltrion Healthcare, will oversee the global sales division. Seo Jin-jin, the eldest son of Celltrion Group Chairman, Seo Jin-seok, chairman of Celltrion's board of directors, has become the head of the management business division.

Celltrion said it held a board meeting on the 28th and decided on a senior agenda to merge with integrated Celltrion and change it to a three-member representative system. Integrated Celltrion plans to achieve its sales target of 12 trillion won by 2030 by strengthening its competitiveness through the unification of its business structure from development to sales and rapidly increasing its product portfolio.

In the future, Celltrion will operate as a representative system for each of the three members. The company deployed Vice Chairman Ki of the manufacturing and development division, Vice Chairman Kim of the global sales division, and Chairman Seo of the management business division to focus on a quick and innovative decision-making structure.

Celltrion has secured large-scale resources by integrating assets previously distributed between the two companies, and will be able to invest more actively in new growth engines such as the development of biosimilars and new drug pipelines, licensing, mergers and acquisitions (M & A) and digital healthcare.

Through the unification of the business structure, the sales cost rate, which is currently about 70%, will be gradually reduced to about 40%, and opportunities to enter new markets and participate in bidding will be expanded. Based on the lower cost ratio, the company plans to expand its presence in major markets and increase sales and market share rapidly.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Korea’s National Pension Service Gains Strong Q3 Returns from U.S. Tech Stocks Amid Market Rally2025.11.07
Eastar Jet Founder Lee Sang-jik Acquitted in Hiring Irregularities Case on Appeal2025.11.06
SK & AWS Ulsan AI Data Center Plan Faces Delay as Ulsan Mipo Industrial Complex Excluded from Korea’s Distributed Energy Special Zone2025.11.06
Seoul High Prosecutors’ Office Launches Search of Ssangbangwool Group Subsidiary Amid Allegations of “Salmon & Soju Party” Witness Bribery in North-Korea Remittance Probe2025.11.06
National Pension Service of Korea to Support Elon Musk’s Compensation Package at Tesla; Opposes AI-Startup Investment Proposal2025.11.06
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사